Cargando…

Adjuvant Treatment Modalities, Prognostic Predictors and Outcomes of Uterine Carcinosarcomas

PURPOSE: The purpose of this study is to evaluate the clinicopathological characteristics, treatment, and prognosis of uterine carcinosarcoma (UC). MATERIALS AND METHODS: A retrospective review of three cancer registry databases in Turkey was conducted for identification of patients diagnosed with U...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gungorduk, Kemal, Ozdemir, Aykut, Ertas, Ibrahim E., Gokcu, Mehmet, Telli, Elcin, Oge, Tufan, Sahbaz, Ahmet, Sayhan, Sevil, Sanci, Muzaffer, Harma, Mehmet, Ozalp, Sinan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398122/ https://www.ncbi.nlm.nih.gov/pubmed/25358384 http://dx.doi.org/10.4143/crt.2014.009

Ejemplares similares

Prognostic Significance of Retroperitoneal Lymphadenectomy, Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Primary Fallopian Tube Carcinoma: A Multicenter Study
por: Gungorduk, Kemal, et al.
Publicado: (2015)

Is the measurement of the size of uterine lesions with positron emission tomography consistent in pre- and postmenopausal periods in endometrioid-type endometrial cancer?
por: Gülseren, Varol, et al.
Publicado: (2018)

The prognostic significance of the heterologous component in uterine carcinosarcomas
por: Can, Behzat, et al.
Publicado: (2023)

The clinical significance of lymphovascular space invasion in patients with low-risk endometrial cancer
por: Çakır, İlker, et al.
Publicado: (2023)

Borderline ovarian tumors: clinical characteristics, management, and outcomes - a multicenter study
por: Gokcu, Mehmet, et al.
Publicado: (2016)

Ultrasonography, macroscopy, and frozen section: whıch is better for predicting deep myometrial invasıon in endometrial cancer?
por: Ozdemir, Cem Yagmur, et al.
Publicado: (2023)

cERBB-2/Her-2 Neu Overexpression and Prognostic Significance in Uterine Carcinosarcoma
por: Semiz, Huseyin Salih, et al.
Publicado: (2023)

An analysis of 37 patients with uterine leiomyosarcoma at a high-volume cancer center
por: Solmaz, Ulaş, et al.
Publicado: (2015)

Effect of the pulmonary recruitment maneuver on pain after laparoscopic gynecological oncologic surgery: a prospective randomized trial
por: Güngördük, Kemal, et al.
Publicado: (2018)

Prognostic factors and treatment outcomes in surgically-staged non-invasive uterine clear cell carcinoma: a Turkish Gynecologic Oncology Group study
por: Sarı, Mustafa Erkan, et al.
Publicado: (2017)

Ruptured Granulosa Cell Tumor of the Ovary as a Cause of Acute Abdomen in Postmenopausal Woman
por: Oge, Tufan, et al.
Publicado: (2012)

Are patients and physicians willing to accept less-radical procedures for cervical cancer?
por: Gungorduk, Kemal, et al.
Publicado: (2018)

Postmenopausal Tuberculosis Endometritis
por: Güngördük, Kemal, et al.
Publicado: (2007)

Trends of uterine carcinosarcoma in the United States
por: Matsuo, Koji, et al.
Publicado: (2018)

Carcinosarcoma of the Thyroid Gland
por: Ekici, Mehmet Fatih, et al.
Publicado: (2015)

Uterine Carcinosarcoma in a Patient with Didelphys Uterus
por: Iavazzo, C., et al.
Publicado: (2013)

Role of TGF-β signaling in uterine carcinosarcoma
por: Dhar Dwivedi, Shailendra Kumar, et al.
Publicado: (2015)

Identification of distinct molecular subtypes of uterine carcinosarcoma
por: An, Yang, et al.
Publicado: (2017)

Targeting the TGFβ pathway in uterine carcinosarcoma
por: Dwivedi, Shailendra Kumar Dhar, et al.
Publicado: (2020)

Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas
por: Sertier, Anne-Sophie, et al.
Publicado: (2023)

Fatal pulmonary thromboembolism associated with uterine carcinosarcoma
por: Lodetti, Giorgia, et al.
Publicado: (2023)

Which is worse: uterine papillary serous carcinomas or carcinosarcomas?
por: Song, Taejong, et al.
Publicado: (2011)

Carcinosarcoma of the uterine cervix arising from Müllerian ducts
por: Kim, Myounghwan, et al.
Publicado: (2015)

Port-Site Metastasis of Uterine Carcinosarcoma after Laparoscopy
por: Tan, Zhen, et al.
Publicado: (2017)

Brain Metastasis in a Young Patient with Uterine Carcinosarcoma
por: Katiyar, Vatsala, et al.
Publicado: (2019)

Clinical utility of CA-125 in the management of uterine carcinosarcoma
por: Matsuo, Koji, et al.
Publicado: (2018)

In‐depth molecular profiling of the biphasic components of uterine carcinosarcomas
por: McConechy, Melissa K, et al.
Publicado: (2015)

Uterine Carcinosarcoma: A Case Report and Literature Review
por: Kord, Ali, et al.
Publicado: (2020)

The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas
por: Moukarzel, Lea A., et al.
Publicado: (2021)

Prognostic value of the TCGA molecular classification in uterine carcinosarcoma
por: Travaglino, Antonio, et al.
Publicado: (2021)

Clostridium and Bacteroides bacteremia as initial presentation of uterine carcinosarcoma
por: Imo, Chinonye S., et al.
Publicado: (2022)

Influence of Clinical and Surgical Factors on Uterine Carcinosarcoma Survival
por: Gracia, Myriam, et al.
Publicado: (2023)

HER2 Oncogene as Molecular Target in Uterine Serous Carcinoma and Uterine Carcinosarcoma
por: McNamara, Blair, et al.
Publicado: (2023)

Müllerian Cyst of the Vagina Masquerading as a Cystocele
por: Töz, Emrah, et al.
Publicado: (2015)

The influence of adjuvant radiotherapy on patterns of failure and survivals in uterine carcinosarcoma
por: Park, Hae Jin, et al.
Publicado: (2011)

Role of MRI in uterine didelphys with co-existing endometrial carcinosarcoma
por: McGregor, Jill, et al.
Publicado: (2018)

Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives
por: Vitale, Salvatore Giovanni, et al.
Publicado: (2017)

OSucs: An Online Prognostic Biomarker Analysis Tool for Uterine Carcinosarcoma
por: An, Yang, et al.
Publicado: (2020)

Cancer antigen 125 is associated with disease status in uterine carcinosarcoma
por: Ross, Malcolm Strachan, et al.
Publicado: (2019)

Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma
por: Hunt, Jonathan T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r97d0r4v28iral6ed3tll4l30o